Facebook-f Linkedin Twitter

TOP STORIES

Precision in NSCLC Treatment: The Predictive Power of TROP2-QCS in Datopotamab Deruxtecan Therapy

N for Narcolepsy- Part I

CAHn you do it?

Stay up to date with MedNess

All bite-size biopharma and medtech news right in your inbox

Medness neuro

Mission Therapeutics starts a clinical trial on its Parkinson’s Disease lead, MTX325

Supplemental Biologics License Application for intravenous maintenance dosing of Alzheimer’s drug, LEQEMBI

Aquinnah’s potential Alzheimer’s drug capable of reducing ~70% brain tau pathology 

AbbVie acquires Mitokinin in its Neuroscience pipeline

Vaccines

Recommendations of the advisory committee on pneumococcal immunization practices

New recommendations for influenza vaccine composition

diagnostics

Personal Genome Diagnostics

Foundation Medicine

Exact Sciences

Natera’s evolution in molecular diagnostics

op-eds

Lack of ethnic diversity in Alzheimer’s disease clinical trials – how patients of color get side-lined.

News archive

.

Stay up-to-date with our biotech and Onco News

Facebook Linkedin Twitter

MedNess Plus

About Us

Disclaimer: The editors take care to share authentic information. In case of any discrepancies please write to newsletter @ medness.org
The sponsors do not have any influence on the nature or kind of the news/analysis reported in MedNess. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of MedNess. Examples of analysis performed within this article are only examples. They should not be utilized in real-world analytic products as they are based only on very limited and dated open source information. Assumptions made within the analysis are not reflective of the position of anyone volunteering or working for MedNess. This blog is strictly for news and information. It does not provide medical advice, diagnosis or treatment nor investment suggestions. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. MedNess is a part of STEMPeers® which is a 501(c)(3) organization registered in PA as PhD Career Support Group. The organization helps create a growing network of STEM scientists that is involved in peer to peer mentoring and support.

Facebook Linkedin Twitter

Onco-This-Week

MedNess Plus

About Us

Disclaimer: The editors take care to share authentic information. In case of any discrepancies please write to newsletter @ medness.org
The sponsors do not have any influence on the nature or kind of the news/analysis reported in MedNess. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of MedNess. Examples of analysis performed within this article are only examples. They should not be utilized in real-world analytic products as they are based only on very limited and dated open source information. Assumptions made within the analysis are not reflective of the position of anyone volunteering or working for MedNess. This blog is strictly for news and information. It does not provide medical advice, diagnosis or treatment nor investment suggestions. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. MedNess is a part of STEMPeers® which is a 501(c)(3) organization registered in PA as PhD Career Support Group. The organization helps create a growing network of STEM scientists that is involved in peer to peer mentoring and support.

Join our Mailing list!

Get all latest biotech news and Onco News.